The 28-day Survival Rates of Two Cytokine-adsorbing Hemofilters for Continuous Renal Replacement Therapy: a Single-center Retrospective Comparative Study

Overview

Journal Acute Med Surg

Specialty Critical Care

Date 2019 Jan 18

PMID 30651999

Citations 11

Authors

Shuichi Kobashi

Takaaki Maruhashi

Tomoya Nakamura

Erika Hatabayashi

Akihide Kon

Affiliations

Soon will be listed here.

Abstract

Aim: Continuous renal replacement therapy (CRRT) with a cytokine-adsorbing hemofilter (CAH) is effective in the treatment of sepsis. Two filter types, namely polymethyl methacrylate (PMMA) and surface-treated AN69 (AN69ST) hemofilters, have been successfully used for CRRT, but no direct comparisons have been published to date. This study compared the efficacy, as measured by 28-day survival rates, of PMMA and AN69ST hemofilters in patients receiving CAH-CRRT.

Methods: This retrospective observational study reviewed the medical records of 142 patients who received CAH-CRRT between November 2013 and February 2015.

Results: The 28-day survival rates were higher in the AN69ST group than in the PMMA group for patients with or without sepsis (all patients, 79.4% versus 54.1%; patients with sepsis, 77.3% versus 50.0%; patients without sepsis, 83.3% versus 57.5%; < 0.05). No significant differences were observed regarding 28-day survival rates of patients with or without sepsis (AN69ST, 77.3% versus 83.3%; = 0.51; PMMA, 50.0% versus 57.5%; = 0.61) using the same hemofilter.

Conclusion: The AN69ST hemofilter could be more effective than PMMA hemofilters for improving the survival outcomes of patients with or without sepsis.

Citing Articles

The Relationship Between Acute-Phase Circuit Occlusion and Blood Calcium Concentration in an Ex Vivo Continuous Renal Replacement Therapy Model.

Kashima Y, Koami H, Sakamoto Y Cureus. 2024; 16(4):e59330.

PMID: 38817525 PMC: 11139355. DOI: 10.7759/cureus.59330.

Blood Purification in Patients with Sepsis Associated with Acute Kidney Injury: A Narrative Review.

Kamei J, Kanamoto M, Igarashi Y, Suzuki K, Fujita K, Kuwana T J Clin Med. 2023; 12(19).

PMID: 37835031 PMC: 10573845. DOI: 10.3390/jcm12196388.

Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial.

Nakamura Y, Hatomoto H, Yamasaki S, Yamauchi K, Kiyomi F, Hoshino K Eur J Med Res. 2023; 28(1):208.

PMID: 37391846 PMC: 10314474. DOI: 10.1186/s40001-023-01184-6.

Rationale for sequential extracorporeal therapy (SET) in sepsis.

Ronco C, Chawla L, Husain-Syed F, Kellum J Crit Care. 2023; 27(1):50.

PMID: 36750878 PMC: 9904264. DOI: 10.1186/s13054-023-04310-2.

Additive effectiveness of acrylonitrile-co-methallyl sulfonate surface-treated membranes in the treatment of pneumonia: A propensity score-matched retrospective cohort study.

Hayashi K, Sasabuchi Y, Matsui H, Nakajima M, Ohbe H, Fushimi K Artif Organs. 2022; 47(2):408-416.

PMID: 36310400 PMC: 10099711. DOI: 10.1111/aor.14435.

References

Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P . Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000; 356(9223):26-30. DOI: 10.1016/S0140-6736(00)02430-2. View

Nakada T, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R . Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med. 2008; 14(5-6):257-63. PMC: 2263139. DOI: 10.2119/2007-00108.Nakada. View

Palevsky P, Zhang J, OConnor T, Chertow G, Crowley S, Choudhury D . Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008; 359(1):7-20. PMC: 2574780. DOI: 10.1056/NEJMoa0802639. View

Rimmele T, Assadi A, Cattenoz M, Desebbe O, Lambert C, Boselli E . High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant. 2008; 24(2):421-7. DOI: 10.1093/ndt/gfn518. View

Rittirsch D, Flierl M, Ward P . Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008; 8(10):776-87. PMC: 2786961. DOI: 10.1038/nri2402. View

Cinel I, Opal S . Molecular biology of inflammation and sepsis: a primer. Crit Care Med. 2008; 37(1):291-304. DOI: 10.1097/CCM.0b013e31819267fb. View

Yamashita A, Tomisawa N . Importance of membrane materials for blood purification devices in critical care. Transfus Apher Sci. 2009; 40(1):23-31. DOI: 10.1016/j.transci.2008.11.005. View

Vesconi S, Cruz D, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A . Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care. 2009; 13(2):R57. PMC: 2689504. DOI: 10.1186/cc7784. View

Cruz D, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A . Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009; 301(23):2445-52. DOI: 10.1001/jama.2009.856. View

10.

Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S . Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009; 361(17):1627-38. DOI: 10.1056/NEJMoa0902413. View

11.

Abe R, Oda S, Shinozaki K, Hirasawa H . Continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter for severe acute pancreatitis. Contrib Nephrol. 2010; 166:54-63. DOI: 10.1159/000314852. View

12.

Thomas M, Moriyama K, Ledebo I . AN69: Evolution of the world's first high permeability membrane. Contrib Nephrol. 2011; 173:119-129. DOI: 10.1159/000328961. View

13.

Matsuda K, Moriguchi T, Harii N, Yanagisawa M, Harada D, Sugawara H . Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure. Contrib Nephrol. 2011; 173:182-190. DOI: 10.1159/000329058. View

14.

Miyamoto T, Yoshimoto A, Tatsu K, Ikeda K, Ishii Y, Kobayashi T . Zero mortality of continuous veno-venous hemodiafiltration with PMMA hemofilter after pediatric cardiac surgery. Ann Thorac Cardiovasc Surg. 2011; 17(4):352-5. DOI: 10.5761/atcs.oa.10.01584. View

15.

Yumoto M, Nishida O, Moriyama K, Shimomura Y, Nakamura T, Kuriyama N . In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration. Ther Apher Dial. 2011; 15(4):385-93. DOI: 10.1111/j.1744-9987.2011.00971.x. View

16.

Hirasawa H, Oda S, Nakamura M, Watanabe E, Shiga H, Matsuda K . Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis. Blood Purif. 2012; 34(2):164-70. DOI: 10.1159/000342379. View

17.

Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal S . Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41(2):580-637. DOI: 10.1097/CCM.0b013e31827e83af. View

18.

Joannes-Boyau O, Honore P, Perez P, Bagshaw S, Grand H, Canivet J . High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med. 2013; 39(9):1535-46. DOI: 10.1007/s00134-013-2967-z. View

19.

Shiga H, Hirasawa H, Nishida O, Oda S, Nakamura M, Mashiko K . Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report. Blood Purif. 2014; 38(3-4):211-8. DOI: 10.1159/000369377. View

20.

Payen D, Guilhot J, Launey Y, Lukaszewicz A, Kaaki M, Veber B . Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015; 41(6):975-84. PMC: 4477725. DOI: 10.1007/s00134-015-3751-z. View